Navigation Links
FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
Date:12/30/2011

in any of the individual REMS programs will be automatically enrolled in the shared system in March 2012.

"ProStrakan is thrilled to see our hard work and the work of the industry working group culminate in this approval," said Anthony G. Oladipo, Pharm.D., M.P.H, BCPS, VP Global Head of Drug Safety & Risk Management, ProStrakan, Inc. "We are fully committed to patient safety and pleased to help the FDA achieve its goal of assuring appropriate use of pain medications."

ProStrakan's product, ABSTRAL is the first and only rapidly-disintegrating tablet placed under the tongue for breakthrough cancer pain. In January 7, 2011 it was approved by the FDA for use in cancer patients, 18 years of age or older, who are already receiving, and who are tolerant to, opioid therapy for their underlying persistent cancer pain.

"ABSTRAL provides a simple, patient-friendly and efficacious treatment option for cancer patients with breakthrough pain, which can be incapacitating, limiting patients' ability to participate in daily activities," said John Higgins, General Manager, ProStrakan, Inc. "Now, all TIRF products will be administered equally through a single REMS, making the process simpler for prescribers, patients, pharmacists, and distributors."

Breakthrough cancer pain, common in up to two-thirds of people with cancer-related pain, affects a patient's quality of life, including physical and emotional health, interpersonal relationships and the ability to engage in certain activities. Breakthrough pain (BTP) is described as severe pain that "breaks through" the patient's round-the-clock pain medicine.[i] Opioids are among the most potent and effective analgesics, or medicines given to reduce pain, but unfortunately are also some of the most misused and abused medicines.

For more information on ABSTRAL, please visit www.ABSTRAL.com. For more information on the TIRF REMS Access program, please visit '/>"/>

SOURCE ProStrakan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 Amerivet Solutions, LLC ( AMERIVET ... of government from Federal to Municipal, is pleased ... to include complex metal design and fabrication manufacturing. ... complex aluminum parts for the Defense Logistics Agency ... to service government contracts," states Richard Bergen ...
(Date:6/19/2013)... 19, 2013 DST Health Solutions, LLC (DSTHS), ... health plans, integrated delivery systems, and health care providers, ... Management Service (MDMS) has jumped significantly. ... the pricing of medical prescription drug claims, MDMS ... their medical drug claims processes. As specialty drug demand ...
(Date:6/19/2013)... June 19, 2013 /PRNewswire-iReach/ -- Today leading web researchers ... data ranking Pharmaceutical web sites for usability, engagement, and ... Experience Cloud platform, which compares how people experience sites ... web. The top three performers are easier ... overall. The bottom performers have usability problems, lack aspects ...
Breaking Medicine Technology:Amerivet Solutions Expands to Manufacture Complex Metal Designs 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2
... Fourth Annual Medical Product Outsourcing (MPO) Symposium kicks off ... strategist and entrepreneur Julia S. Rasor, founder of the ... device manufacturing efficiency by providing real-world examples of rudimentary ... flounder as different functional groups do their best to ...
... General Dynamics Information Technology, a business unit of ... awarded a contract to support the U.S. Army Medical ... medical facilities and transition to newly constructed facilities. The ... awarded by the U.S. Army Corps of Engineers, has ...
Cached Medicine Technology:MPO Symposium Keynote to Address Organizational Strategies for Medical Device Manufacturers 2General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities 2General Dynamics Awarded Contract to Outfit and Transition U.S. Army Medical Facilities 3
(Date:6/19/2013)... Citi Bike has come to New York City in a big ... for sure how many patients will choose to take advantage of ... In fact, he’s happy about anything that might help his ... convenient for them to visit his office at 133 East 58th ... at Back and Body Medical and an experienced NYC chiropractor ...
(Date:6/19/2013)... 2013 The Journal of Parasitology – ... computer software, it creates questions of ethics. For scientific ... an already published case shows, scientific publications need clear ... The Journal of Parasitology features a commentary ... 2004 article published in the Journal of the New ...
(Date:6/19/2013)... LOS ANGELES (June 19, 2013) In what is ... with the most common form of hereditary dystonia ... experts in deep brain stimulation report good success ... director of the Movement Disorders Program at Cedars-Sinai Medical ... chief of the Division of Neurosurgery at Beth Israel ...
(Date:6/19/2013)... understanding of the genetic process that can lead to ... lesions for some women, and also raises a warning ... cases suggesting they could actually trigger the cancer ... a clearer picture of the chromosomal and genetic changes ... to chronic infection and, in less than 1 percent ...
(Date:6/19/2013)... For those familiar ... name of the 10/90 gap: only 10 per cent of ... 90 per cent of the global disease burden. It was ... initiative (DNDi) came into being in 2003. Coinciding with its ... Foundation Frontiers of Knowledge Award in the Development Cooperation category. ...
Breaking Medicine News(10 mins):Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 2Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 3Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 4Health News:DNDi receives the BBVA Foundation Frontiers of Knowledge Award in Development Cooperation 5
... by progressive memory loss, decline in language skills and ... ageing population.// ,A recent paper in the ... in drug discovery. Hong-Yu Zhang, the author of the ... strategy in drug discovery is limited, which has stimulated ...
... responds to a diverse range of insults, such as ... wide range of cell types of the immune system, ... The inflammatory response, although essential for fighting infection, may ... anti-inflammatory mediators, cytokines and lipid mediators being the key ...
... Thompson and colleagues from University of Rochester Medical ... patients treated with corticosteroids that Corticosteroids is the ... mononucleosis, including severe airway compromise mononucleosis. The results ... of Otolaryngology – Head and Neck Surgery, JAMA ...
... of adults, rates of some pain conditions - particularly ... ranging from 20-50% of the teenage population.// ... are more prevalent in adult women than in men. ... associated with increased risk of migraine. Use of hormone ...
... for the development of kidney disease and is the ... However, whether pre-diabetes is associated with the development of ... declines in kidney function are present early on among ... to prevent the progression of kidney disease. Recently, researchers, ...
... have discovered that a deceptively simple sugar is in ... ,The discovery reveals that, when disturbed, this process ... to properly control the steps and timing of cell ... as O-GlcNAc (pronounced oh-GLUCK-nack), is used inside cells to ...
Cached Medicine News:Health News:The ideal composition of intravenous lipid emulsion 2Health News:Pubertal development may predispose women to pain and other symptoms 2Health News:Development of kidney disease in adults with pre-diabetes 2Health News:Sugar Helps Control Cell Division 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: